<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77122">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01749345</url>
  </required_header>
  <id_info>
    <org_study_id>17676</org_study_id>
    <secondary_id>1K24DK093699-01</secondary_id>
    <nct_id>NCT01749345</nct_id>
  </id_info>
  <brief_title>Social Determinants of Health in Diabetes Outcomes</brief_title>
  <official_title>Social Determinants of Health as Explanatory Factors for Ethnic Disparities in Diabetes Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ralph H. Johnson VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional study of six hundred adults with type 2 diabetes, (300 White and
      300 African-American) who will be recruited from two primary care sites to determine how
      social determinants of health impact diabetes outcomes. The first aim is to investigate the
      role of psychosocial factors and SES on diabetes care processes and outcomes. The second aim
      is to investigate the influence of community and neighborhood characteristics on diabetes
      care processes and outcomes. Finally, we will examine the contribution of social
      determinants of health to ethnic differences in diabetes care processes and outcomes.
      Clinical and metabolic measures will be abstracted from the electronic medical records.
      Outcome variables include hemoglobin A1c, blood pressure, LDL-Cholesterol and quality of
      life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>HbA1C</measure>
    <time_frame>Within 3 months prior to the assessment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Within a month of completely the assessment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Most recent to assessment date</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low density lipoprotein (LDL) Cholesterol</measure>
    <time_frame>Most recent to assessment date</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pimary care and internal medicine clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of type 2 diabetes

          -  Able to communicate in English

        Exclusion Criteria:

          -  Mental confusion on interview suggesting significant dementia

          -  Alcohol or drug abuse/dependency

          -  Active psychosis or acute mental disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonard E Egede, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Smalls, MHSA</last_name>
      <phone>843-876-0698</phone>
      <email>smallsbr@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joni Strom, MD</last_name>
      <phone>843-792-0906</phone>
      <email>stromjl@musc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Leonard E Egede, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ralph H. Johnson VA Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebekah Walker, MS</last_name>
      <phone>843-789-7587</phone>
      <email>rebekah.walker@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Lois Idleman, MSN</last_name>
      <phone>843-789-6624</phone>
      <email>lois.idleman@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Leonard E. Egede, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>December 11, 2012</lastchanged_date>
  <firstreceived_date>December 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
